Skip to main content

Home/ Cancer/ Group items tagged study men

Rss Feed Group items tagged

Matti Narkia

Inverse association between serum 25(OH) vitamin D levels and non-melanoma skin cancer ... - 0 views

  •  
    Inverse association between serum 25(OH) vitamin D levels and non-melanoma skin cancer in elderly men.
    Tang JY, Parimi N, Wu A, John Boscardin W, Shikany JM, Chren MM, Cummings SR, Epstein EH Jr, Bauer DC; for the Osteoporotic Fractures in Men (MrOS) Study Group.
    Cancer Causes Control. 2009 Nov 18. [Epub ahead of print]
    PMID: 19921445

    Our results suggest that a diagnosis of NMSC is not a surrogate for adequate 25(OH)D levels or increased UV exposure, and high 25(OH)D levels may be associated with a reduced risk of NMSC.
Matti Narkia

Pilot study: potential role of vitamin D (Cholecalciferol) in patients with PSA relapse... - 0 views

  •  
    Pilot study: potential role of vitamin D (Cholecalciferol) in patients with PSA relapse after definitive therapy.
    Woo TC, Choo R, Jamieson M, Chander S, Vieth R.
    Nutr Cancer. 2005;51(1):32-6.
    PMID: 15749627
Matti Narkia

Serum Vitamin D and Risk of Prostate Cancer in a Case-Control Analysis Nested Within th... - 0 views

  •  
    Serum Vitamin D and Risk of Prostate Cancer in a Case-Control Analysis Nested Within the European Prospective Investigation into Cancer and Nutrition (EPIC).
    Travis RC, Crowe FL, Allen NE, Appleby PN, Roddam AW, Tjønneland A, Olsen A, Linseisen J, Kaaks R, Boeing H, Kröger J, Trichopoulou A, Dilis V, Trichopoulos D, Vineis P, Palli D, Tumino R, Sieri S, Bueno-de-Mesquita HB, van Duijnhoven FJ, Chirlaque MD, Barricarte A, Larrañaga N, González CA, Argüelles MV, Sánchez MJ, Stattin P, Hallmans G, Khaw KT, Bingham S, Rinaldi S, Slimani N, Jenab M, Riboli E, Key TJ.
    Am J Epidemiol. 2009 Apr 9. [Epub ahead of print]
    PMID: 19359375
    doi:10.1093/aje/kwp022
Matti Narkia

Phase I clinical trial of a selective inhibitor of CYP17, abiraterone acetate, confirms... - 0 views

  •  
    Phase I clinical trial of a selective inhibitor of CYP17, abiraterone acetate, confirms that castration-resistant prostate cancer commonly remains hormone driven.
    Attard G, Reid AH, Yap TA, Raynaud F, Dowsett M, Settatree S, Barrett M, Parker C, Martins V, Folkerd E, Clark J, Cooper CS, Kaye SB, Dearnaley D, Lee G, de Bono JS.
    J Clin Oncol. 2008 Oct 1;26(28):4563-71. Epub 2008 Jul 21.
    PMID: 18645193
    DOI: 10.1200/JCO.2007.15.9749
Matti Narkia

Dietary Omega-3 Fatty Acids, Cyclooxygenase-2 Genetic Variation, and Aggressive Prostat... - 0 views

  •  
    Dietary Omega-3 Fatty Acids, Cyclooxygenase-2 Genetic Variation, and Aggressive Prostate Cancer Risk.
    Fradet V, Cheng I, Casey G, Witte JS.
    Clin Cancer Res. 2009 Mar 24. [Epub ahead of print]
    PMID: 19318492
    DOI: 10.1158/1078-0432.CCR-08-2503
Matti Narkia

Bioavailability and Kinetics of Sulforaphane in Humans after Consumption of Cooked vers... - 0 views

  •  
    Bioavailability and Kinetics of Sulforaphane in Humans after Consumption of Cooked versus Raw Broccoli
    Martijn Vermeulen*, Ineke W. A. A. Klpping-Ketelaars†, Robin van den Berg‡ and Wouter H. J. Vaes
    J. Agric. Food Chem., 2008, 56 (22), pp 10505-10509
    Publication Date (Web): October 24, 2008 (Article)
    DOI: 10.1021/jf801989e
Matti Narkia

Prospective study of predictors of vitamin D status and cancer incidence and mortality ... - 0 views

  •  
    Giovannucci E, Liu Y, Rimm EB, Hollis BW, Fuchs CS, Stampfer MJ, Willett WC.
    Prospective study of predictors of vitamin D status and cancer incidence and mortality in men.
    J Natl Cancer Inst. 2006 Apr 5;98(7):451-9.
    PMID: 16595781 [PubMed - indexed fo
Matti Narkia

Prospective study of predictors of vitamin D status and cancer incidence and mortality ... - 0 views

  •  
    Giovannucci E, Liu Y, Rimm EB, Hollis BW, Fuchs CS, Stampfer MJ, Willett WC.
1 - 8 of 8
Showing 20 items per page